FDA Greenlights Mirikizumab for Ulcerative Colitis Therapy

Press/Media

Period	28 Oct 2023

Media coverage

Title	FDA Greenlights Mirikizumab for Ulcerative Colitis Therapy
Media name/outlet	Mirage News
Country/Territory	Australia
Date	28/10/23
URL	ct.moreover.com/?a=52180663678&p=1gw&v=1&x=86sSHEBIRb-Rx36BrRy6_A
Persons	Bruce E. Sands